- Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
-
Kelvin H. M. Kwok, Karen S. L. Lam
-
Endocrinol Metab. 2017;32(2):145-151. Published online May 19, 2017
-
DOI: https://doi.org/10.3803/EnM.2017.32.2.145
-
-
4,224
View
-
43
Download
-
7
Web of Science
-
5
Crossref
-
Abstract
PDFPubReader ePub
Fibroblast growth factor 21 (FGF21) is an atypical member of the FGF family. Acting in an endocrine fashion, it increases glucose uptake, modulates lipid metabolism, and sensitizes insulin response in metabolically active organs, including the liver and adipose tissue. Emerging evidence shows a strong correlation between circulating FGF21 levels and the incidence and severity of atherosclerosis. Animal studies have demonstrated a beneficial role of FGF21 in protecting against aberrant lipid profile, while recent development in FGF21 mimetics has provided further insight into the lipid-lowering effects of FGF21 signaling. The present review summarizes the physiological roles of FGF21, and discusses major breakthroughs and limitations of FGF21 mimetic-based therapeutic strategies for treating atherosclerosis.
-
Citations
Citations to this article as recorded by
- Higher fasting fibroblast growth factor 21 was associated with a greater decline in postprandial blood pressure
Jane Yu Ying Ong, Kaveri Pathak, Yun Zhao, Emily Calton, Christopher M. Reid, Mario J. Soares Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(2): 102720. CrossRef - Potential role of fibroblast growth factor 21 in the deterioration of bone quality in impaired glucose tolerance
D. T. W. Lui, C. H. Lee, V. W. K. Chau, C. H. Y. Fong, K. M. Y. Yeung, J. K. Y. Lam, A. C. H. Lee, W. S. Chow, K. C. B. Tan, Y. C. Woo, K. S. L. Lam Journal of Endocrinological Investigation.2021; 44(3): 523. CrossRef - FGF21 induces autophagy‐mediated cholesterol efflux to inhibit atherogenesis via RACK1 up‐regulation
Lin Xiaolong, Guo Dongmin, Mihua Liu, Wang Zuo, Hu Huijun, Tan Qiufen, Hu XueMei, Lin Wensheng, Pan Yuping, Lin Jun, Zeng Zhaolin Journal of Cellular and Molecular Medicine.2020; 24(9): 4992. CrossRef - Two-hundred-liter scale fermentation, purification of recombinant human fibroblast growth factor-21, and its anti-diabetic effects on ob/ob mice
Qi Hui, Zhen Huang, Shucai Pang, Xuanxin Yang, Jinghang Li, Bingjie Yu, Lu Tang, Xiaokun Li, Xiaojie Wang Applied Microbiology and Biotechnology.2019; 103(2): 719. CrossRef - Protection Effect of Exogenous Fibroblast Growth Factor 21 on the Kidney Injury in Vascular Calcification Rats
Yu-Chen Shi, Wei-Wei Lu, Yue-Long Hou, Kun Fu, Feng Gan, Shu-Juan Cheng, Shao-Ping Wang, Yong-Fen Qi, Jing-Hua Liu Chinese Medical Journal.2018; 131(5): 532. CrossRef
|